Diagnostic solutions  using fast and powerful genomic analyses.

Analyzing DNA directly on our novel microchip provides rapid and accurate results from a user-friendly system.  LiDia can operate in a variety of hospital environments close to the point of need, with flexible levels of throughput to match a wide range of clinical demands.

LiDia launches with a groundbreaking rapid direct-from-specimen test for bloodstream infections that lead to sepsis, followed by a pipeline of tests that provide fast results for serious medical applications such as cancer monitoring.

Bringing Cutting Edge Technology to the Patient

We have pioneered the use of semiconductor microchips to analyze DNA, leading to simple-to-use systems that produce fast results.

Our innovative application of semiconductor chip technology means LiDia can perform a range of genomic analyses depending on the application – from highly parallel individual tests to powerful next generation sequencing (NGS).

Combating sepsis and the global threat of

antimicrobial resistance

Over the last few years there has been a galvanizing of

action, both within the clinical and political communities, to

tackle the alarming rise of antimicrobial resistance (AMR).

Strong focus is being placed on reducing overuse and

misdirected use of antibiotics.

LiDia is uniquely positioned to respond to the growing

threat of AMR. In September 2016, DNAe was awarded up to $51.9M contract by the Biomedical Advanced Research and Development Authority, a division of the Office of the Assistant Secretary for Preparedness and Response in the US Health and Human Services to develop a semiconductor DNA sequencing platform for rapid diagnosis of antimicrobial resistant infections and influenza.

Current vacancies:

Work with us

​

AND BEGIN A FASCINATING

JOURNEY OF DISCOVERY

We’re creating something radically different products that change the game for early diagnosis and monitoring of potentially fatal diseases. The work we do at DNAe helps save lives, this is a powerful motivator and a glorious reason to get involved.

US Careers

​

UK Careers

​